|
 | Up a level |
Piggott, Thomas, Moja, Lorenzo, Jenei, Kristina, Kredo, Tamara, Skoetz, Nicole, Banzi, Rita, Trapani, Dario, Leong, Trudy, McCaul, Michael, Lavis, John N., Akl, Elie A., Nonino, Francesco, Iorio, Alfonso, Laurson-Doube, Joanna, Huttner, Benedikt D. and Schünemann, Holger J. (2024) GRADE Concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists. Journal of Clinical Epidemiology, 166. ISSN 0895-4356
Jenei, Kristina, Lythgoe, Mark P. and Vokinger, Kerstin N. (2024) Shortages of essential cancer medicines: who is responsible and what are the possible solutions? The Lancet Oncology, 25 (1). 23 - 26. ISSN 1470-2045
Jenei, Kristina and Meyers, Daniel (2023) Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations. BMJ Open, 13 (10). ISSN 2044-6055
Jenei, Kristina, Raymakers, Adam J.N., Bayle, Arnaud, Berger-Thürmel, Karin, Cherla, Avi, Honda, Kazunori, Jackson, Christopher C.G.A., Karikios, Deme, Trapani, Dario, Berry, Scott and Gyawali, Bishal (2023) Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology, 24 (6). pp. 624-635. ISSN 1470-2045
Jenei, Kristina, Meyers, Daniel and Gyawali, Bishal (2023) Assessment of price and clinical benefit of cancer drugs in Canada, 2011-2020. JAMA network open, 6 (1). e2253438. ISSN 2574-3805
Jenei, Kristina, Meyers, Daniel and Gyawali, Bishal (2023) Price and clinical benefit of cancer drugs in Canada, 2011-2020. JAMA network open. ISSN 2574-3805
